The United States government sued Johnson & Johnson claiming that the company paid millions of dollars in kickbacks to the Omnicare pharmacy chain to buy and recommend medications.

According to the lawsuit filed January 15, 2010, Johnson & Johnson made payments to Omnicare, the nations largest senior care pharmacy, in exchange for buying and recommending Johnson & Johnson drugs, including its antipsychotic medication Risperdal. The payments allegedly persuaded Omnicare pharmacies to switch patients from other anti-psychotic medications to Risperdal.

Johnson & Johnson argues that it did not violate the False Claims act or Anti-Kickback statute. The company claims the United States government is trying to brand allowable rebates as illegal.

The Qui Tam attorneys of Tycko & Zavareei LLP are experienced in healthcare fraud investigations and litigation, and are here to help you with a free, confidential, initial consultation. Contact us at 202-973-0900 today.